INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 103 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $15,000 | +36.4% | 3,200 | 0.0% | 0.00% | – |
Q4 2018 | $11,000 | -65.6% | 3,200 | 0.0% | 0.00% | – |
Q3 2018 | $32,000 | +39.1% | 3,200 | 0.0% | 0.00% | – |
Q2 2018 | $23,000 | +21.1% | 3,200 | 0.0% | 0.00% | – |
Q1 2018 | $19,000 | -38.7% | 3,200 | 0.0% | 0.00% | – |
Q4 2017 | $31,000 | +10.7% | 3,200 | 0.0% | 0.00% | – |
Q3 2017 | $28,000 | -30.0% | 3,200 | 0.0% | 0.00% | – |
Q2 2017 | $40,000 | +21.2% | 3,200 | 0.0% | 0.00% | – |
Q1 2017 | $33,000 | +10.0% | 3,200 | 0.0% | 0.00% | – |
Q4 2016 | $30,000 | -60.5% | 3,200 | -50.0% | 0.00% | – |
Q3 2016 | $76,000 | +85.4% | 6,400 | +100.0% | 0.00% | – |
Q2 2016 | $41,000 | -19.6% | 3,200 | 0.0% | 0.00% | – |
Q1 2016 | $51,000 | -44.6% | 3,200 | 0.0% | 0.00% | – |
Q4 2015 | $92,000 | +1.1% | 3,200 | 0.0% | 0.00% | – |
Q3 2015 | $91,000 | -27.8% | 3,200 | -9.0% | 0.00% | – |
Q2 2015 | $126,000 | +23.5% | 3,518 | +99.1% | 0.00% | – |
Q1 2015 | $102,000 | +1357.1% | 1,767 | +958.1% | 0.00% | – |
Q4 2014 | $7,000 | – | 167 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 6,171,440 | $54,802,000 | 0.52% |
Regal Investment Advisors LLC | 161,600 | $1,435,000 | 0.34% |
Folger Hill Asset Management LP | 396,315 | $3,519,000 | 0.30% |
SCHNEIDER CAPITAL MANAGEMENT CORP | 181,900 | $1,615,000 | 0.29% |
Mirae Asset Global Investments Co., Ltd. | 1,033,683 | $9,179,000 | 0.17% |
JW Asset Management, LLC | 29,409 | $72,000 | 0.05% |
TCI Wealth Advisors, Inc. | 9,516 | $85,000 | 0.04% |
GAM Holding AG | 83,940 | $745,000 | 0.03% |
Freedom Investment Management, Inc. | 63,032 | $560,000 | 0.03% |
Sterling Investment Advisors, Ltd. | 5,000 | $44,000 | 0.03% |